High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha

Biochemical and Biophysical Research Communications

Volumn 315, Issue 1, 2004, Pages 235-239

  Song, Houhui ^a   Zhou, Li ^a   Fang, Weihuan ^b   Li, Yong ^a   Wang, Xu ^a   Fang, Hongbo ^c   Li, Xiangdong ^c   Wu, Mingyu ^d   Qiu, Bingsheng ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cholera toxin B subunit; Epitope; Foot and mouth disease virus; Hansenula polymorpha; Synonymous codon

Indexed keywords

BACTERIUM ANTIBODY; CAPSID PROTEIN; CARBON DIOXIDE; CHIMERIC PROTEIN; CHOLERA TOXIN B SUBUNIT; EPITOPE; FOOT AND MOUTH DISEASE VIRUS ANTIBODY; GANGLIOSIDE GM1; GANGLIOSIDE GM1 RECEPTOR; PROTEIN VP1; RECEPTOR; RESIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CHIMERA; CODON; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA SEQUENCE; DRUG ANTIGENICITY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; FUSION GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC CODE; HANSENULA POLYMORPHA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; VIRUS GENE; WESTERN BLOTTING;

FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE; PICHIA ANGUSTA;

EID: 0842286544     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.037     Document Type: Article

References (21)

1. Parry N., Fox G., Rowlands D., Brown F., Fry E., Acharya R., Logan D., Stuart D. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature. 347:1990;569-572.
2. Schiappacassi M., Rieder Rojas E., Carrillo E., Campos R. Response of foot-and-mouth disease virus C3 Resende to immunological pressure exerted in vitro by antiviral polyclonal sera. Virus Res. 36:1995;77-85.
3. Blanco E., Garcia-Briones M., Sanz-Parra A., Gomes P., De Oliveira E., Valero M.L., Andreu D., Ley V., Sobrino F. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J. Virol. 75:2001;3164-3174.
4. Zamorano P.I., Wigdorovitz A., Perez Filgueira D.M., Escribano J.M., Sadir A.M., Borca M.V. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1. Vaccine. 16:1998;558-563.
5. Wong H.T., Cheng S.C., Chan E.W., Sheng Z.T., Yan W.Y., Zheng Z.X., Xie Y. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology. 278:2000;27-35.
6. Dus Santos M.J., Wigdorovitz A., Trono K., Rios R.D., Franzone P.M., Gil F., Moreno J., Carrillo C., Escribano J.M., Borca M.V. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine. 20:2002;1141-1147.
7. Wong H.T., Cheng S.C., Sin F.W., Chan E.W., Sheng Z.T., Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine. 20:2002;2641-2647.
8. O'Hagan D.T., Ott G.S., Van Nest G. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. Mol. Med. Today. 3:1997;69-75.
9. Holmgren J., Czerkinsky C., Eriksson K., Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine. 21(Suppl. 2):2003;S89-S95.
10. Boyaka P.N., Ohmura M., Fujihashi K., Koga T., Yamamoto M., Kweon M.N., Takeda Y., Jackson R.J., Kiyono H., Yuki Y., McGhee J.R. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit. J. Immunol. 170:2003;454-462.
11. Albu D.I., Jones-Trower A., Woron A.M., Stellrecht K., Broder C.C., Metzger D.W. Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. J. Virol. 77:2003;5589-5597.
12. George-Chandy A., Eriksson K., Lebens M., Nordstrom I., Schon E., Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect. Immun. 69:2001;5716-5725.
13. Gellissen G., Janowicz Z.A., Weydemann U., Melber K., Strasser A.W., Hollenberg C.P. High-level expression of foreign genes in Hansenula polymorpha. Biotechnol. Adv. 10:1992;179-189.
14. Gellissen G. Heterologous protein production in methylotrophic yeasts. Appl. Microbiol. Biotechnol. 54:2000;741-750.
15. Withers-Martinez C., Carpenter E.P., Hackett F., Ely B., Sajid M., Grainger M., Blackman M.J. PCR-based gene synthesis as an efficient approach for expression of the A+T-rich malaria genome. Protein Eng. 12:1999;1113-1120.
16. Song H., Li Y., Fang W., Geng Y., Wang X., Wang M., Qiu B. Development of a set of expression vectors in Hansenula polymorpha. Biotechnol. Lett. 25:2003;1999-2006.
17. Chung C.T., Niemela S.L., Miller R.H. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. USA. 86:1989;2172-2175.
18. Jani D., Meena L.S., Rizwan-ul-Haq Q.M., Singh Y., Sharma A.K., Tyagi A.K. Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res. 11:2002;447-454.
19. Sinclair G., Choy F.Y. Synonymous codon usage bias and the expression of human glucocerebrosidase in the methylotrophic yeast, Pichia pastoris. Protein Expr. Purif. 26:2002;96-105.
20. Yu P., Neamati N., Tarasov S., He Q., Sheikh M.S., Wang Y.X. Codon-optimized cloning, expression and characterization of the C-terminal region of human apoptotic protein GADD34 in Escherichia coli. Cell Cycle. 3:2004;75-79.
21. Kotula L., Curtis P.J. Evaluation of foreign gene codon optimization in yeast: expression of a mouse IG kappa chain. Biotechnology. 9:1991;1386-1389.